The TRIM28/miR133a/CD47 axis acts as a potential therapeutic target in pancreatic necrosis by impairing efferocytosis
- PMID: 38872307
- PMCID: PMC11403229
- DOI: 10.1016/j.ymthe.2024.06.005
The TRIM28/miR133a/CD47 axis acts as a potential therapeutic target in pancreatic necrosis by impairing efferocytosis
Abstract
Efferocytosis, the clearance of apoptotic cells by macrophages, plays a crucial role in inflammatory responses and effectively prevents secondary necrosis. However, the mechanisms underlying efferocytosis in acute pancreatitis (AP) remain unclear. In this study, we demonstrated the presence of efferocytosis in injured human and mouse pancreatic tissues. We also observed significant upregulation of CD47, an efferocytosis-related the "do not eat me" molecule in injured acinar cells. Subsequently, we used CRISPR-Cas9 gene editing, anti-adeno-associated virus (AAV) gene modification, and anti-CD47 antibody to investigate the potential therapeutic role of AP. CD47 expression was negatively regulated by upstream miR133a, which is controlled by the transcription factor TRIM28. To further investigate the regulation of efferocytosis and reduction of pancreatic necrosis in AP, we used miR-133a-agomir and pancreas-specific AAV-shTRIM28 to modulate CD47 expression. Our findings confirmed that CD47-mediated efferocytosis is critical for preventing pancreatic necrosis and suggest that targeting the TRIM28-miR133a-CD47 axis is clinically relevant for the treatment of AP.
Keywords: acute pancreatitis; apoptotic cell clearance; clinical translation; immune microenvironment.
Copyright © 2024 The American Society of Gene and Cell Therapy. Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of interests The authors declare no competing interests.
Similar articles
-
Development of Pro-resolving and Pro-efferocytic Nanoparticles for Atherosclerosis Therapy.ACS Pharmacol Transl Sci. 2024 Sep 13;7(10):3086-3095. doi: 10.1021/acsptsci.4c00292. eCollection 2024 Oct 11. ACS Pharmacol Transl Sci. 2024. PMID: 39416959
-
Resolvin E1 improves efferocytosis and rescues severe aplastic anemia in mice.Cell Death Dis. 2024 May 9;15(5):324. doi: 10.1038/s41419-024-06705-7. Cell Death Dis. 2024. PMID: 38724533 Free PMC article.
-
Ex vivo engineering of phagocytic signals in breast cancer cells for a whole tumor cell-based vaccine.BMC Cancer. 2025 Jul 1;25(1):1029. doi: 10.1186/s12885-025-14432-1. BMC Cancer. 2025. PMID: 40596971 Free PMC article.
-
Serum C-reactive protein, procalcitonin, and lactate dehydrogenase for the diagnosis of pancreatic necrosis.Cochrane Database Syst Rev. 2017 Apr 21;4(4):CD012645. doi: 10.1002/14651858.CD012645. Cochrane Database Syst Rev. 2017. PMID: 28431197 Free PMC article.
-
Novel immunotherapy for gastric cancer: targeting the CD47-SIRPα axis.Cancer Metastasis Rev. 2025 May 29;44(2):52. doi: 10.1007/s10555-025-10269-z. Cancer Metastasis Rev. 2025. PMID: 40437298 Review.
Cited by
-
Mechanistic insights into the regression of atherosclerotic plaques.Front Physiol. 2024 Nov 19;15:1473709. doi: 10.3389/fphys.2024.1473709. eCollection 2024. Front Physiol. 2024. PMID: 39628943 Free PMC article. Review.
-
Engineering Efferocytosis for Bone Regeneration.Macromol Biosci. 2025 Jul 4:e00094. doi: 10.1002/mabi.202500094. Online ahead of print. Macromol Biosci. 2025. PMID: 40614242 Review.
-
Inhibition of CD53 Reduces the Formation of ROS-Induced Neutrophil Extracellular Traps and Protects Against Inflammatory Injury in Acute Pancreatitis.J Inflamm Res. 2025 Mar 13;18:3725-3739. doi: 10.2147/JIR.S507886. eCollection 2025. J Inflamm Res. 2025. PMID: 40098997 Free PMC article.
-
Identification of Grb2 protein as a potential mediator of macrophage activation in acute pancreatitis based on bioinformatics and experimental verification.Front Immunol. 2025 May 26;16:1575880. doi: 10.3389/fimmu.2025.1575880. eCollection 2025. Front Immunol. 2025. PMID: 40491924 Free PMC article.
-
Annexin A1 mRNA-loaded liposomes alleviate acute pancreatitis by suppressing STING pathway and promoting efferocytosis in macrophages.Nat Nanotechnol. 2025 Aug 11. doi: 10.1038/s41565-025-01979-0. Online ahead of print. Nat Nanotechnol. 2025. PMID: 40789923
References
-
- Mederos M.A., Reber H.A., Girgis M.D. Acute Pancreatitis: A Review. Jama. 2021;325:382–390. - PubMed
-
- Sendler M., Dummer A., Weiss F.U., Krüger B., Wartmann T., Scharffetter-Kochanek K., van Rooijen N., Malla S.R., Aghdassi A., Halangk W., et al. Tumour necrosis factor α secretion induces protease activation and acinar cell necrosis in acute experimental pancreatitis in mice. Gut. 2013;62:430–439. - PubMed
-
- Sendler M., Weiss F.U., Golchert J., Homuth G., van den Brandt C., Mahajan U.M., Partecke L.I., Döring P., Gukovsky I., Gukovskaya A.S., et al. Cathepsin B-Mediated Activation of Trypsinogen in Endocytosing Macrophages Increases Severity of Pancreatitis in Mice. Gastroenterology. 2018;154:704–718.e10. - PMC - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous